Feldan Therapeutics and Elasmogen announce research agreement with Amgen
Agreement to develop intracellular biologics
10-May-2017 -
Elasmogen Ltd, focused on the development of next generation biologics, and Feldan Therapeutics, focused on intracellular delivery of proteins, today announce a research collaboration with Amgen, to develop and deliver novel intracellular biologics. The collaboration combines the unique ...
Amgen
biologics
collaborations
+3